JNJ
Johnson & Johnson CEDEAR
Stock
Stock
ISIN: ARDEUT110236
Ticker: JNJ3
ARDEUT110236
JNJ3
Price
Price
CHART BY
Frequently asked questions
What is Johnson & Johnson CEDEAR's market capitalization?
The market capitalization of Johnson & Johnson CEDEAR is $406.33T. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Johnson & Johnson CEDEAR's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Johnson & Johnson CEDEAR is 36.65. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Johnson & Johnson CEDEAR?
Johnson & Johnson CEDEAR's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $306.92. EPS indicates the company's profitability on a per-share basis.
What is Johnson & Johnson CEDEAR's revenue over the trailing twelve months?
Over the trailing twelve months, Johnson & Johnson CEDEAR reported a revenue of $68.23T.
What is the EBITDA for Johnson & Johnson CEDEAR?
Johnson & Johnson CEDEAR's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $22.84T. EBITDA measures the company's overall financial performance.
What is the free cash flow of Johnson & Johnson CEDEAR?
Johnson & Johnson CEDEAR has a free cash flow of $14.91T. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Johnson & Johnson CEDEAR have, and what sector and industry does it belong to?
Johnson & Johnson CEDEAR employs approximately 131,900 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
Financials
- Market Cap
- $406.33T
- EPS (TTM)
- $306.92
- P/E ratio (TTM)
- 36.65
- Revenue (TTM)
- $68.23T
- EBITDA (TTM)
- $22.84T
- Free Cashflow (TTM)
- $14.91T
Pricing
- 52W span
- $10.24$17.51
Information
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
- Employees
- 131,900
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- ARDEUT110236
- Primary Ticker
- JNJ3